article thumbnail

Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers

European Pharmaceutical Review

This poses a significant challenge for pharmaceutical manufacturers, not least because of the technical challenges related to operations, supply chain and the environment. This article explores the potential impact of the proposal and considers how manufacturers can ensure the safety and reliability of their products.

article thumbnail

Leading retail pharmacies in pharma

Pharmaceutical Technology

Increasing diagnosis of chronic diseases is expected to lead to fast growth in retail pharmacies. The rising incidence of long-standing diseases such as hypertension, diabetes, cardiovascular diseases, and cancer requires prolonged medication and, thus, drives the growth and need for retail pharmacies in the market. Speciality care.

Retail 45
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Breaking Down Patient Access Barriers

PM360

Innovative financial access platforms can connect patients with charitable foundations, government programs, and manufacturer-sponsored assistance plans, helping them access additional resources for treatments and prescriptions. Healthcare patients are also bringing retail-inspired consumer expectations to their care experience.

article thumbnail

PhRMA lies to protect pharma profits

World of DTC Marketing

The online retailer spends about $20 billion a year on R&D, despite being renowned for low prices and low profits. But of all the companies in the world, the one that invests the most in research and development is not a drug company. It’s Amazon.

Pharma 255
article thumbnail

Revolutionizing MedTech: Dive Into Medical Sales Strategies With Paul Hoffschmidt

Evolve Your Success

As a long-time consultant at Oliver Wyman, he worked with manufacturers and retailers to improve processes and unlock efficiencies in the consumer goods industry. Over the past decade, he has been a regular angel investor and company builder, typically focusing on data-driven topics.

article thumbnail

Drug pricing increases are disgraceful

World of DTC Marketing

However, because of manufacturer discounts and rebates, the extent to which increases in wholesale list prices are associated with amounts paid by patients and insurers is poorly characterized. The online retailer spends about $20 billion a year on R&D, despite being renowned for both low prices and low profits. It’s Amazon.

Insurance 181
article thumbnail

Co-bots and automatons: the divergent futures of robotics

Pharmaceutical Technology

Robots are already vital in a number of sectors, from manufacturing to retail, and their use will only grow.

Retail 52